Complete Surgical Excision Is the Most Effective Treatment for BI-ALCL
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
Phase 4 study data presented at the American Academy of Pain Medicine PainConnect 2026 meeting reported that more than 90% of patients undergoing aesthetic or reconstructive procedures remained opioid-free when treated with Journavx as part of multimodal pain therapy.